A detailed history of Waterfront Wealth Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Waterfront Wealth Inc. holds 3,795 shares of CRL stock, worth $734,522. This represents 0.19% of its overall portfolio holdings.

Number of Shares
3,795
Previous 3,711 2.26%
Holding current value
$734,522
Previous $766,000 2.48%
% of portfolio
0.19%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$187.96 - $245.29 $15,788 - $20,604
84 Added 2.26%
3,795 $747,000
Q2 2024

Aug 01, 2024

BUY
$206.39 - $268.73 $18,575 - $24,185
90 Added 2.49%
3,711 $766,000
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $736,945 - $990,090
3,621 New
3,621 $981,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.84B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Waterfront Wealth Inc. Portfolio

Follow Waterfront Wealth Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waterfront Wealth Inc., based on Form 13F filings with the SEC.

News

Stay updated on Waterfront Wealth Inc. with notifications on news.